- Home
- KROS vs ASPI Comparison
KROS vs ASPI Comparison
Compare KROS & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ASPI
- Stock Information
- Founded
- KROS 2015
- ASPI 2021
- Country
- KROS United States
- ASPI United States
- Employees
- KROS N/A
- ASPI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- KROS Health Care
- ASPI Industrials
- Exchange
- KROS Nasdaq
- ASPI Nasdaq
- Market Cap
- KROS 565.0M
- ASPI 653.4M
- IPO Year
- KROS 2020
- ASPI 2022
- Fundamental
- Price
- KROS $14.51
- ASPI $10.10
- Analyst Decision
- KROS Buy
- ASPI Strong Buy
- Analyst Count
- KROS 13
- ASPI 2
- Target Price
- KROS $20.63
- ASPI $7.75
- AVG Volume (30 Days)
- KROS 450.7K
- ASPI 4.6M
- Earning Date
- KROS 08-06-2025
- ASPI 08-18-2025
- Dividend Yield
- KROS N/A
- ASPI N/A
- EPS Growth
- KROS N/A
- ASPI N/A
- EPS
- KROS 0.11
- ASPI N/A
- Revenue
- KROS $214,713,000.00
- ASPI $4,405,477.00
- Revenue This Year
- KROS $5,390.70
- ASPI $512.64
- Revenue Next Year
- KROS N/A
- ASPI $181.15
- P/E Ratio
- KROS $133.17
- ASPI N/A
- Revenue Growth
- KROS 91657.70
- ASPI 245.97
- 52 Week Low
- KROS $9.12
- ASPI $1.86
- 52 Week High
- KROS $72.37
- ASPI $10.82
- Technical
- Relative Strength Index (RSI)
- KROS 58.66
- ASPI 62.26
- Support Level
- KROS $14.18
- ASPI $9.33
- Resistance Level
- KROS $14.85
- ASPI $10.82
- Average True Range (ATR)
- KROS 0.55
- ASPI 0.87
- MACD
- KROS 0.04
- ASPI 0.21
- Stochastic Oscillator
- KROS 71.78
- ASPI 82.44
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.